Victor Ambros ’75, PhD ’79 and Gary Ruvkun share Nobel Prize in Physiology or Medicine
The scientists, who worked together as postdocs at MIT, are honored for their discovery of microRNA — a class of molecules that are critical for gene regulation.
The scientists, who worked together as postdocs at MIT, are honored for their discovery of microRNA — a class of molecules that are critical for gene regulation.
MIT’s innovation and entrepreneurship system helps launch water, food, and ag startups with social and economic benefits.
At the cutting edge of pedagogy, Mary Ellen Wiltrout has shaped blended and online learning at MIT and beyond.
For Sarah Sterling, the new director of the Cryo-Electron Microscopy facility at MIT.nano, better planning and more communication leads to better science.
In animal models, even low stimulation currents can sometimes still cause electrographic seizures, researchers found.
PhD student Oscar Molina seeks new ways to assemble proteins into targeted cancer therapies, while also encouraging his fellow first-generation graduate students.
By unraveling the genetic pathways that help Toxoplasma gondii persist in human cells, Sebastian Lourido hopes to find new ways to treat toxoplasmosis.
Amulya Aluru ’23, MEng ’24 and the MIT Spokes have spent the summer spreading science, over 3,000 miles on two wheels.
Fasting helps intestinal stem cells regenerate and heal injuries but also leads to a higher risk of cancer in mice, MIT researchers report.
The Future African Scientist organization was sparked by a connection between two students from different walks of life during an MIT program in South Africa.
Four faculty members and four others with MIT ties are recognized for pushing the boundaries of science and for creating highly inclusive and collaborative research environments.
Custom plates display expressions of scholarship, creativity, and MIT pride among Institute affiliates.
PhD student Xinyi Zhang is developing computational tools for analyzing cells in the age of multimodal data.
Through academia and industry, Gevorg Grigoryan PhD ’07 says there is no right path — just the path that works for you.
A new gene-silencing tool shows promise as a future therapy against prion diseases and paves the way for new approaches to treating disease.